TacticScale

What Zhejiang NHU (新和成) Does & How It Makes Money (002001.SZ)

Updated October 2026 · reflects Zhejiang NHU's latest reported financials

Chinese maker of vitamins, flavors, fragrances, and specialty chemicals. NHU sells industrial-scale nutritional, aroma, polymer and chemical products to feed producers, food and beverage brands, consumer-goods companies and pharmaceutical manufacturers in China and abroad.

Zhejiang NHU's story, moat and numbers — in a 3-minute visual book.

Explore Zhejiang NHU on TacticScale →

How Zhejiang NHU makes money

NHU sells industrial-scale nutritional, aroma, polymer and chemical products to feed producers, food and beverage brands, consumer-goods companies and pharmaceutical manufacturers in China and abroad. Revenue comes largely from its Pharmaceutical and Chemical segment, with exports adding to domestic sales, alongside professional services for drug-preparation companies.

What Zhejiang NHU does

Zhejiang NHU Company Ltd., incorporated in 1999 and headquartered in Xinchang, China, is a diversified producer of nutritional products, flavors and fragrances, polymer materials and active pharmaceutical ingredients. Its nutrition business spans human vitamins (A, D3, E, H, C and the B group), coenzyme Q10, beta carotene and taurine for supplements, food and beverages and personal care, alongside animal nutrition products such as methionine, biotin and carotenoids for poultry, swine, ruminants and farmed fish.

Products & services

新和成是做什么的?

浙江新和成股份有限公司成立于1999年,总部位于中国浙江新昌,业务涵盖营养品、香精香料、高分子新材料和原料药,下设医药化工及其他分部。营养品业务包括面向保健品、食品饮料和个人护理的人类营养素(维生素A、D3、E、H、C及B族、辅酶Q10、β-胡萝卜素、牛磺酸等),以及面向禽类、猪、反刍动物和水产养殖的动物营养产品,如蛋氨酸、生物素、氨基酸和类胡萝卜素。 公司同时生产芳樟醇、柠檬醛、薄荷醇、二氢茉莉酮酸甲酯等香精香料,用于肥皂、牙膏、洗发水及食品饮料;并供应PPS/PPA树脂、PPS纤维与薄膜等高分子材料,以及异佛尔酮、丙烯酸、环戊酮等化工产品。新和成产品行销国内外,并为制剂企业提供专业服务,母公司为新和成控股集团有限公司。

What is Zhejiang NHU worth?

On an owner-earnings DCF, Zhejiang NHU's most-likely value is about ¥46 versus a recent price near ¥26 (42% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~¥16) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.

Verdict: Fairly priced — no edge
Owner-earnings fair value · recent price ≈ ¥26
Fair value (most likely)
¥46
Range
¥30–¥75
No-growth floor
¥16
Price
~¥26

Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.

Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →

Sector Healthcare Industry Drug Manufacturers - Specialty & Generic HQ China Ticker 002001.SZ Official site

Related companies

Zhejiang Medicine (600216.SS) · Zhejiang Huahai Pharmaceutical (600521.SS) · MeiHua (600873.SS) · Zhejiang Hisun Pharmaceutical (600267.SS) · Zhejiang Juhua (600160.SS)